Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mezzopram 20mg dispersible gastro-resistant tablets (Sandoz)
0103050P0BGABAN
|
Mezzopram | Omeprazole | Gastro-Intestinal System | 2,685 |
|
Mezzopram 10mg dispersible gastro-resistant tablets (Sandoz)
0103050P0BGAAAM
|
Mezzopram | Omeprazole | Gastro-Intestinal System | 1,821 |
|
Mezzopram 40mg dispersible gastro-resistant tablets (Sandoz)
0103050P0BGACAP
|
Mezzopram | Omeprazole | Gastro-Intestinal System | 386 |
|
Mezzopram 10mg dispersible gastro-resistant tab (NorthStar)
0103050P0BGADAM
|
Mezzopram | Omeprazole | Gastro-Intestinal System | 1 |
|
Mezzopram 20mg dispersible gastro-resistant tab (NorthStar)
0103050P0BGAEAN
|
Mezzopram | Omeprazole | Gastro-Intestinal System | No data available |
|
Mezzopram 40mg dispersible gastro-resistant tab (NorthStar)
0103050P0BGAFAP
|
Mezzopram | Omeprazole | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.